We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$16B
AUM Growth
+$1.49B
Cap. Flow
+$904M
Cap. Flow %
5.66%
Top 10 Hldgs %
21.47%
Holding
2,613
New
47
Increased
594
Reduced
1,043
Closed
153

Sector Composition

Rank Sector Weight
1 Financials 23.01%
2 Technology 13.32%
3 Healthcare 10.73%
4 Industrials 9.87%
5 Consumer Discretionary 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WRLD icon
1801
World Acceptance Corp
WRLD
$875M
$418K ﹤0.01%
5,045
RESI
1802
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$418K ﹤0.01%
37,657
-319
-0.8% -$3.89K
COHU icon
1803
Cohu
COHU
$2.76B
$417K ﹤0.01%
17,501
NEO icon
1804
NeoGenomics
NEO
$2.11B
$417K ﹤0.01%
37,432
-1,409
-4% -$13.7K
MBUU icon
1805
Malibu Boats
MBUU
$573M
$416K ﹤0.01%
13,158
WLH
1806
DELISTED
WILLIAM LYON HOMES
WLH
$416K ﹤0.01%
18,074
CRVL icon
1807
CorVel
CRVL
$3.25B
$415K ﹤0.01%
22,872
GNC
1808
DELISTED
GNC Holdings, Inc.
GNC
$415K ﹤0.01%
46,936
-324
-0.7% -$2.92K
NEX
1809
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$414K ﹤0.01%
24,799
UFI icon
1810
UNIFI
UFI
$120M
$412K ﹤0.01%
11,561
-457
-4% -$14.4K
MGNX icon
1811
MacroGenics
MGNX
$259M
$411K ﹤0.01%
22,224
RIGL icon
1812
Rigel Pharmaceuticals
RIGL
$762M
$411K ﹤0.01%
16,182
+6,853
+73% +$167K
RUTH
1813
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$411K ﹤0.01%
19,623
RATE
1814
DELISTED
Bankrate Inc
RATE
$410K ﹤0.01%
29,420
-1,076
-4% -$14.9K
ORIT
1815
DELISTED
Oritani Financial Corp. New
ORIT
$409K ﹤0.01%
24,321
-937
-4% -$15.4K
LXRX icon
1816
Lexicon Pharmaceuticals
LXRX
$1.04B
$408K ﹤0.01%
33,202
PRO
1817
DELISTED
PROS Holdings
PRO
$407K ﹤0.01%
16,872
SNEX icon
1818
StoneX
SNEX
$8.05B
$407K ﹤0.01%
53,784
BJRI icon
1819
BJ's Restaurants
BJRI
$1.42B
$406K ﹤0.01%
13,332
LAUR icon
1820
Laureate Education
LAUR
$5.15B
$405K ﹤0.01%
27,816
NBIX icon
1821
Neurocrine Biosciences
NBIX
$15.3B
$404K ﹤0.01%
6,588
+336
+5% +$17.7K
OLED icon
1822
Universal Display
OLED
$4.18B
$404K ﹤0.01%
3,137
+160
+5% +$19.4K
HSTM icon
1823
HealthStream
HSTM
$849M
$403K ﹤0.01%
17,224
CUTR
1824
DELISTED
Cutera, Inc.
CUTR
$403K ﹤0.01%
9,744
HSKA
1825
DELISTED
Heska Corp
HSKA
$403K ﹤0.01%
4,574

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2017 Portfolio in Review

As of Q3 2017, Metropolitan Life Insurance Company (MetLife) held 2,613 positions worth $16B, up 10% from $14.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Metropolitan Life Insurance Company (MetLife) deployed $904M of net new capital in Q3 2017, opening 47 new positions and adding to 594 existing holdings. Its largest new stake was Brighthouse Financial: 23,194,796 shares worth $1.36B.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $211M trimmed.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2017 buy was Brighthouse Financial: 23,194,796 shares worth $1.36B.
  • Metropolitan Life Insurance Company (MetLife) added most to Bank of America in Q3 2017, an estimated $109M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2017 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $211M.
  • Metropolitan Life Insurance Company (MetLife) fully exited CVS Health in Q3 2017, selling an estimated $39.7M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 21% of its $16B portfolio in Q3 2017.
  • Metropolitan Life Insurance Company (MetLife) opened 47 new positions and closed 153 in Q3 2017.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 10% quarter-over-quarter to $16B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2017, filed 14 Nov 2017.